Wearable, self-administered transcranial photobiomodulation for major depressive disorder and sleep: A randomized, double blind, sham-controlled trial
Self-administered wearable tPBM appears to be a feasible and well-tolerated in MDD patients. The low-level dosimetry appeared insufficient to produce an antidepressant effect but effective in improving sleep quality. Further studies should investigate different dosimetry and intervention time. CLINICAL TRIALS REGISTRATION NUMBER IN CLINICALTRIAL.GOV: NCT04619121.
Authors
- Yi‐Ting Lin (ORCID: https://orcid.org/0000-0002-5833-0040)
- Ta‐Wei Guu (ORCID: https://orcid.org/0000-0002-2621-0781)
- Kuan‐Pin Su (ORCID: https://orcid.org/0000-0002-4501-2502)
- Wan-Jing Li
- Wen-Yu Ho
- Paolo Cassano (ORCID: https://orcid.org/0000-0003-0225-199X)
- Jane Pei‐Chen Chang (ORCID: https://orcid.org/0000-0001-5582-0928)
- Yuan-Ling Tseng
- Shuhao Lin (ORCID: https://orcid.org/0000-0002-7982-746X)
- David Mischoulon (ORCID: https://orcid.org/0000-0001-7233-5860)
Institutions
- Asia University (TW)
- China Medical University (TW)
- Massachusetts General Hospital (US)
- An-Nan Hospital (TW)
- China Medical University Beigang Hospital (TW)
- China Medical University Hospital (TW)
Publication Details
- Journal
- Journal of Affective Disorders
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1016/j.jad.2024.12.065
- Citations
- 10
- Primary Topic
- Laser Applications in Dentistry and Medicine
- Type
- article
- Field-Weighted Citation Impact
- 4.04